Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret E Gerbasi

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Personality and Social Psychology|June 26, 2013
The Self- and Other-Interest InventoryMargaret E Gerbasi, Deborah A Prentice
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|May 9, 2022
Epidemiology of Pediatric Essential Tremor in the United States: A Systematic Literature Review from 2010 to 2020Margaret E Gerbasi, Adi Eldar-Lissai, Kelly E Lyons
Health Behavior and Policy Review|June 4, 2019
Social Norms and Smoking Risk in <i>iTaukei</i> Fijian Adolescent WomenMargaret E Gerbasi, Stephen E Gilman, Asaf Bitton, et al.
Frontiers in Neurology|August 8, 2022
Essential tremor patients experience significant burden beyond tremor: A systematic literature reviewMargaret E Gerbasi, Shruti Nambiar, Spencer Reed, et al.
Journal of Women'S Health (2002)|November 12, 2020
Brexanolone in Postpartum Depression: <i>Post Hoc</i> Analyses to Help Inform Clinical Decision-MakingMargaret E Gerbasi, Samantha Meltzer-Brody, Sarah Acaster, et al.
Archives of Women'S Mental Health|July 16, 2020
Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for DepressionMargaret E Gerbasi, Adi Eldar-Lissai, Sarah Acaster, et al.
Journal of Medical Economics|June 22, 2019
Cost-effectiveness of dabrafenib and trametinib in combination as adjuvant treatment of BRAF V600E/K mutation-positive melanoma from a US healthcare payer perspectiveMargaret E Gerbasi, Daniel Stellato, Sameer R Ghate, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|May 6, 2024
Associations Among Tremor Amplitude, Activities of Daily Living, and Quality of Life in Patients with Essential TremorMargaret E Gerbasi, Rodger J Elble, Eddie Jones, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Budget Impact of Dabrafenib and Trametinib in Combination as Adjuvant Treatment of BRAF V600E/K Mutation-Positive Melanoma from a U.S. Commercial Payer PerspectiveDaniel Stellato, Margaret E Gerbasi, Briana Ndife, et al.
Journal of Managed Care & Specialty Pharmacy|March 20, 2020
Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United StatesAdi Eldar-Lissai, Joshua T Cohen, Samantha Meltzer-Brody, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Personality and Social Psychology|June 26, 2013
The Self- and Other-Interest InventoryMargaret E Gerbasi, Deborah A Prentice
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|May 9, 2022
Epidemiology of Pediatric Essential Tremor in the United States: A Systematic Literature Review from 2010 to 2020Margaret E Gerbasi, Adi Eldar-Lissai, Kelly E Lyons
Health Behavior and Policy Review|June 4, 2019
Social Norms and Smoking Risk in <i>iTaukei</i> Fijian Adolescent WomenMargaret E Gerbasi, Stephen E Gilman, Asaf Bitton, et al.
Frontiers in Neurology|August 8, 2022
Essential tremor patients experience significant burden beyond tremor: A systematic literature reviewMargaret E Gerbasi, Shruti Nambiar, Spencer Reed, et al.
Journal of Women'S Health (2002)|November 12, 2020
Brexanolone in Postpartum Depression: <i>Post Hoc</i> Analyses to Help Inform Clinical Decision-MakingMargaret E Gerbasi, Samantha Meltzer-Brody, Sarah Acaster, et al.
Archives of Women'S Mental Health|July 16, 2020
Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for DepressionMargaret E Gerbasi, Adi Eldar-Lissai, Sarah Acaster, et al.
Journal of Medical Economics|June 22, 2019
Cost-effectiveness of dabrafenib and trametinib in combination as adjuvant treatment of BRAF V600E/K mutation-positive melanoma from a US healthcare payer perspectiveMargaret E Gerbasi, Daniel Stellato, Sameer R Ghate, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|May 6, 2024
Associations Among Tremor Amplitude, Activities of Daily Living, and Quality of Life in Patients with Essential TremorMargaret E Gerbasi, Rodger J Elble, Eddie Jones, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Budget Impact of Dabrafenib and Trametinib in Combination as Adjuvant Treatment of BRAF V600E/K Mutation-Positive Melanoma from a U.S. Commercial Payer PerspectiveDaniel Stellato, Margaret E Gerbasi, Briana Ndife, et al.
Journal of Managed Care & Specialty Pharmacy|March 20, 2020
Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United StatesAdi Eldar-Lissai, Joshua T Cohen, Samantha Meltzer-Brody, et al.
Pageof 2